dr-shylaja-srinivasan-md-110-1440x784-2x
Shylaja Srinivasan

Shylaja Srinivasan

MD

Pediatric endocrinologist
Pediatric type 2 diabetes specialist in care and research

Contact me

Contact me

Dr. Shylaja Srinivasan is a pediatric endocrinologist who cares for children with thyroid or adrenal disorders, endocrine conditions related to growth and puberty, bone and calcium disorders, and type 1 or type 2 diabetes. She has a special interest in type 2 diabetes that develops in childhood, an increasingly common condition caused by a complex interplay between genetics and environment.

Srinivasan's research focuses on understanding the genetic factors in type 2 diabetes. Her research also explores the genetic basis for different responses to diabetes medications, particularly metformin.

Originally from Chennai in South India, Srinivasan earned her medical degree at the Pondicherry Institute of Medical Sciences. She completed residencies in pediatrics at SUNY Downstate Health Sciences University and Tufts Medical Center, followed by a Harvard Medical School fellowship in pediatric endocrinology at Massachusetts General Hospital.

In 2016, Srinivasan won the Pediatric Endocrine Society's Clinical Scholar Award, receiving a grant to pursue research in the genetics of type 2 diabetes. She is a member of the Pediatric Endocrine Society, Endocrine Society, American Diabetes Association and American Society of Human Genetics.

  • Board Certifications

    American Board of Pediatrics, Pediatric Endocrinology

    American Board of Pediatrics, Pediatrics

  • Fellowships

    Massachusetts General Hospital GME, Pediatric Endocrinology

  • Residencies

    Tufts Medical Center, Pediatrics

    State University of NY Health Sci Ctr/Brooklyn, Pediatrics

  • Internship

    State University of NY Health Sci Ctr/Brooklyn, Pediatrics

  • Degree

    MBBS, Pondicherry Institute of Medical Sciences and Research

I aim to provide excellent evidence-based, compassionate care to children and their families.

Where I see patients (2)

    Selected research

    See all research
    Decorative Caduceus

    A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diab...

    A summary of treatment emergent adverse events (TEAEs), SAEs and other non-serious adverse events (AEs), regardless of causality, will be reported in the Reported Adverse Events module

    Recruiting

    More about this study
    Decorative Caduceus

    Precision Dosing of Metformin in Youth With T2D

    The perception that a higher dose of Metformin is agreeable or satisfactory measured with the 4-item Acceptability of Intervention Measure (AIM). A 4-item measure of perceived intervention acceptability. Items are measured on a 5-...

    Recruiting

    More about this study
    Decorative Caduceus

    Artificial Intelligence-based Methods to Predict Disease Progression in Youth With Type 2 Diabe...

    The primary outcome will be the ability of the digital twin model to accurately predict longitudinal disease progression measured as the digital twin predicted HbA1C versus measured HbA1C and the difference in HbA1C between the di...

    Recruiting

    More about this study
    See all clinical trials

    Contact me

    Soothing the soul

    Our music therapy program nurtures patients with bedside serenades, rap workshops and more.

    Find out more

    Share